Search Results 551-560 of 2981 for 谷歌日本搜索引入口咨询邮箱：lgooxc@hotmail.com

  1. Laboratories - Mayo Clinic Research

    Gastrointestinal Barrier Function: Madhusudan Grover · Gastrointestinal Mechanotransduction: Arthur Beyder · Gene Editing and Cellular Engineering: David (Chun- ...

  2. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    After completing all screening assessments and meeting all eligibility criteria, subjects will be randomized to receive placebo or AMG 181 at various doses per ...

  3. Serial Venous Blood Sample Collection Before and Following Arteriovenous Fistula Creation or Arteriovenous Graft Placement. - Mayo Clinic

    The purpose of this IRB protocol is to request collection of the venous tissue sample that is produced when the arteriovenous fistula/graft (AVF/AVG) creation ...

  4. Publications - Xiaoning Ding, Ph.D. - Mayo Clinic

    Ding X, Younkin JE, Shen J, Bues M, Liu W. A critical review of the practices of proton daily quality assurance programs. Ther Radiol Oncol. 2021 Dec; 5:22.

  5. Image Acquisition - Imaging Core - Mayo Clinic Research

    The Imaging and Analysis Core of the Mayo Clinic Pirnie Translational Polycystic Kidney Disease Center specializes in developing advanced image acquisition ...

  6. A Study to Evaluate the Safety and Diagnostic Effectiveness of Mangoral in Patients With Focal Liver Lesions and Reduced Kidney Function - Mayo Clinic

    The diagnostic efficacy of Mangoral will be assessed in terms of visualization of detected focal liver lesions in combined MRI (CMRI: combined Mangoral-enhanced ...

  7. Non-Invasive Monitoring of Potassium Levels in Patients with Congestive Heart Failure - Mayo Clinic

    The purpose of this study is to examine that signal processed ECGs can be used to monitor changes in serum concentrations of potassium based on T-wave features.

  8. Allergic Diseases: Hirohito Kita - Research Collaborators

    Dr. Kita and his team in the Allergic Diseases Lab at Mayo Clinic work with numerous other investigators to harness the power of collaboration to advance ...

  9. Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC). - Mayo Clinic

    About this study. This is a randomized, open-label, multi-center, global, Phase III study to determine the efficacy and safety of MEDI4736 + tremelimumab ...

  10. Training opportunities - Genome Function, Stability and Nuclear Organization in Cancer: Veronica Rodriguez-Bravo - Mayo Clinic Research

    Learn about the training opportunities available in Dr. Rodriguez-Bravo's Genome Function, Stability and Nuclear Organization in Cancer at Mayo Clinic.